{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:01:06Z","timestamp":1791993666907,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejphar.2024.176335","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T03:56:03Z","timestamp":1707278163000},"page":"176335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Fucoxanthin mitigates valproic acid-induced autistic behavior through modulation of the AKT\/GSK-3\u03b2 signaling pathway"],"prefix":"10.1016","volume":"967","author":[{"given":"Piyush","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-6632","authenticated-orcid":false,"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176335_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2015.02.041","article-title":"Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism","volume":"286","author":"Al-Amin","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0003-3472(75)90114-1","article-title":"Postnatal development of locomotion in the laboratory rat","volume":"23","author":"Altman","year":"1975","journal-title":"Anim. Behav."},{"key":"10.1016\/j.ejphar.2024.176335_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neubiorev.2021.07.029","article-title":"Autism spectrum disorder: trace elements imbalances and the pathogenesis and severity of autistic symptoms","volume":"129","author":"Baj","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2024.176335_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2011.06.063","article-title":"Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals","volume":"1410","author":"Banji","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib5","series-title":"Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management","first-page":"97","article-title":"Neuropsychopathology of autism spectrum disorder: complex interplay of genetic, epigenetic, and environmental factors","author":"Bhandari","year":"2020"},{"key":"10.1016\/j.ejphar.2024.176335_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2014.06.017","article-title":"Experimenter effects on behavioral test scores of eight inbred mouse strains under the influence of ethanol","volume":"272","author":"Bohlen","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/0471142301.ns0812s15","article-title":"Motor coordination and balance in rodents","volume":"15","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176335_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/md19020114","article-title":"Cytoprotective potential of fucoxanthin in oxidative stress-induced age-related macular degeneration and retinal pigment epithelial cell senescence in vivo and in vitro","volume":"19","author":"Chen","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2024.176335_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2008.02.029","article-title":"Mechanisms of ROS modulated cell survival during carcinogenesis","volume":"266","author":"Clerkin","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2024.176335_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jinorgbio.2017.02.020","article-title":"A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies","volume":"170","author":"Cukierman","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejphar.2024.176335_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0047-6374(87)90051-0","article-title":"Distribution of superoxide dismutase, glutathione peroxidase and catalase in developing rat brain","volume":"41","author":"Del Maestro","year":"1987","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejphar.2024.176335_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/1567205018666211118144602","article-title":"Neuroprotective effect of fucoxanthin against intracerebroventricular streptozotocin (ICV-STZ) induced cognitive impairment in experimental rats","volume":"18","author":"Dhami","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jdn.10005","article-title":"The role of GABAergic neural circuits in the pathogenesis of autism spectrum disorder","volume":"80","author":"Di","year":"2020","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176335_bib14","first-page":"430","article-title":"The role of insulin-like growth factor on autism spectrum disorder","volume":"2","author":"D\u00f6nmez","year":"2021","journal-title":"J. Exp. Basic Med. Sci."},{"key":"10.1016\/j.ejphar.2024.176335_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0024-3205(88)90267-6","article-title":"An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates","volume":"43","author":"Donzanti","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2024.176335_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2024.176335_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijdevneu.2015.11.006","article-title":"Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid-induced rat autism model","volume":"49","author":"Gao","year":"2016","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176335_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11055-021-01117-y","article-title":"Effects of prenatal and early postnatal administration of valproate on behavior and cyhtological characteristics in wistar rats","volume":"51","author":"Gedzun","year":"2021","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.ejphar.2024.176335_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2024.176335_bib20","first-page":"850","article-title":"The effect of ceftriaxone in valproic acid-induced mouse model of autism","volume":"12","author":"Gur","year":"2022","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.ejphar.2024.176335_bib21","first-page":"60","article-title":"Effect of curcumin alone and in combination with eugenol or rosemary acid in valproic acid-induced autism in mice: postnatal model","volume":"7","author":"Harika","year":"2022","journal-title":"Int. J. Appl. Pharm. Sci. Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/jcm11020442","article-title":"Could Candida overgrowth Be involved in the pathophysiology of autism?","volume":"11","author":"Herman","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2024.176335_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fnbeh.2018.00182","article-title":"A developmental study of abnormal behaviors and altered GABAergic signaling in the VPA-treated rat model of autism","volume":"12","author":"Hou","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176335_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11011-016-9902-2","article-title":"Ameliorative effect of kolaviron, a biflavonoid complex from Garcinia kola seeds against scopolamine-induced memory impairment in rats: role of antioxidant defense system","volume":"32","author":"Ishola","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2024.176335_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00775-021-01866-8","article-title":"Allicin ameliorates aluminium-and copper-induced cognitive dysfunction in Wistar rats: relevance to neuro-inflammation, neurotransmitters and A\u03b2 (1\u201342) analysis","volume":"26","author":"Kaur","year":"2021","journal-title":"JBIC, J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejphar.2024.176335_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/gbb.12256","article-title":"Behavioral phenotypes of genetic mouse models of autism","volume":"15","author":"Kazdoba","year":"2016","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.ejphar.2024.176335_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41386-018-0098-5","article-title":"Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism","volume":"44","author":"Kim","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2024.176335_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneurol.2014.187","article-title":"Maternal immune activation and abnormal brain development across CNS disorders","volume":"10","author":"Knuesel","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2024.176335_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158150","article-title":"Behavioral phenotyping of juvenile long-evans and sprague-dawley rats: implications for preclinical models of autism spectrum disorders","volume":"11","author":"Ku","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176335_bib30","article-title":"Valproic acid induces autism-like synaptic and behavioral deficits by disrupting histone acetylation of prefrontal cortex ALDH1A1 in rats","volume":"15","author":"Liu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176335_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176335_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176335_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s12640-020-00169-1","article-title":"Oxiracetam and zinc ameliorates autism-like symptoms in propionic acid model of rats","volume":"37","author":"Paudel","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib34","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s00210-020-01916-z","article-title":"The protective effect of alpha lipoic acid (ALA) on social interaction memory, but not passive avoidance in sleep-deprived rats","volume":"393","author":"Rezaie","year":"2020","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176335_bib35","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s11033-021-06237-9","article-title":"Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes","volume":"48","author":"Rizk","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2024.176335_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/ijp.IJP_183_17","article-title":"Congenital malformation and autism spectrum disorder: insight from a rat model of autism spectrum disorder","volume":"49","author":"Ruhela","year":"2017","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176335_bib37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.118.252635","article-title":"In vivo preclinical molecular imaging of repeated exposure to an N-methyl-d-aspartate antagonist and a glutaminase inhibitor as potential glutamatergic modulators","volume":"368","author":"Servaes","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2024.176335_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neures.2017.10.006","article-title":"Piperine in combination with quercetin halt 6-OHDA induced neurodegeneration in experimental rats: biochemical and neurochemical evidences","volume":"133","author":"Singh","year":"2018","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib39","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/acschemneuro.0c00672","article-title":"Inhibition of the ERK1\/2 phosphorylation by dextromethorphan protects against core autistic symptoms in VPA induced autistic rats: in silico and in vivo drug repurposition study","volume":"12","author":"Singla","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176335_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020470","article-title":"Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders","volume":"6","author":"Suzuki","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176335_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-022-03562-9","article-title":"Transcranial photobiomodulation add-on therapy to valproic acid for pentylenetetrazole-induced seizures in peripubertal rats","volume":"22","author":"Tsai","year":"2022","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.ejphar.2024.176335_bib42","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/cells10040958","article-title":"Dysregulation of multiple signaling neurodevelopmental pathways during embryogenesis: a possible cause of autism spectrum disorder","volume":"10","author":"Upadhyay","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.176335_bib43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/md17120702","article-title":"Fucoxanthin alleviates oxidative stress through Akt\/Sirt1\/FoxO3\u03b1 signaling to inhibit HG-induced renal fibrosis in GMCs","volume":"17","author":"Yang","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2024.176335_bib44","article-title":"Early behavioral abnormalities and perinatal alterations of PTEN\/AKT pathway in valproic acid autism model mice","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176335_bib45","first-page":"7218","article-title":"Effect of fucoxanthin on pi3k\/akt signaling pathway in human cervical cancer hela cells","volume":"9","author":"Ye","year":"2018","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib46","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/aur.2696","article-title":"Global prevalence of autism: a systematic review update","volume":"15","author":"Zeidan","year":"2022","journal-title":"Autism Res."},{"key":"10.1016\/j.ejphar.2024.176335_bib47","article-title":"Fucoxanthin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:29:28Z","timestamp":1757978968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S0014299924000232"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176335","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fucoxanthin mitigates valproic acid-induced autistic behavior through modulation of the AKT\/GSK-3\u03b2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176335"}}